A Study to Assess the Effect of SB 659032 on Platelet Function

Clinical trial NCT01750827 · COMPLETED

Trial details

NCT number: NCT01750827
Sponsor: GlaxoSmithKline
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Atherosclerosis

Start date: 2004-09-01
Primary completion: 2004-11-01
Enrollment: 14

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.